Metraipolis › archive › dc_cb597fcff811

Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a… — Europe PMC PMID:42211494

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211494
DOI
10.3389/fonc.2026.1782296
License (as archived)
solo-consultazione
Archived
2026-11-02T10:29:38.843Z
SHA-256 of the archived text
1e300ac00f79d07674b48498f39c55b65dce0592dc380b9e0faa4c62aa25f433
Stable URL of this page
https://metraipolis.com/documento/dc_cb597fcff811

How to cite

Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a… — Europe PMC PMID:42211494 — Europe PMC (en), https://europepmc.org/article/MED/42211494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb597fcff811 (Metraipolis archive dc_cb597fcff811, sha256 1e300ac00f79d07674b48498f39c55b65dce0592dc380b9e0faa4c62aa25f433)
BibTeX
@misc{dccb597fcff811,
  title = {Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a… — Europe PMC PMID:42211494},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211494},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb597fcff811; sha256 1e300ac00f79d07674b48498f39c55b65dce0592dc380b9e0faa4c62aa25f433},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211494. Agents can read the archived copy with the MCP tool read_document.